Trial NCT03591744

View at ClinicalTrials.gov 
Org. Study IDs: 18162
Secondary IDs: 18162 NCI-2018-01405

Last trial update was posted on 2018-12-19

MeSH Interventions

BB 1101 Bortezomib Daratumumab Dexamethasone Dexamethasone acetate Doxorubicin Ichthammol Lenalidomide Liposomal doxorubicin

MeSH Conditions

Leukemia Leukemia, Plasma Cell

Other Conditions

Plasma Cell Leukemia

Stopping Reasons

Budgetary constraints

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID